Acer Medical, a subsidiary of the Acer group, announced that its AI bone density abnormal screening software "VeriOsteo OP," in collaboration with Taichung Veterans General Hospital (VGHTC), has received approval from the Taiwan Food and Drug Administration...
The article requires paid subscription. Subscribe Now